Grail's cancer blood test faces high-stakes FDA review
- Posted on September 23, 2026
- By The Toronto Star
- 0 Views
- 1 min read
In brief
Generating AI summary…
Grail's cancer blood test faces high-stakes FDA review
WASHINGTON (AP) — A blood test designed to spot signs of multiple cancers in apparently healthy people faces its first major regulatory hurdle Wednesday as advisers to the U.S. government
